Skip to content

Impact of Acute Hospitalisation and Resistance Training on Muscle Architecture and Physical Performance in Older Adults

Impact of Acute Hospitalisation and Resistance Training on Muscle Architecture and Physical Performance in Older Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05798169
Enrollment
274
Registered
2023-04-04
Start date
2023-01-05
Completion date
2024-12-20
Last updated
2025-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acutely Ill, Functional Decline, Gait Speed, Hospitalisation, Muscle Architecture, Older Adults, Physical Performance, Resistance Training, Sarcopenia, Ultrasound

Brief summary

Sarcopenia characterised by loss of muscle mass, muscle strength and physical performance burdens many older adults since the condition is related to functional decline. Periods of inactivity such as during hospitalisation leads to further functional decline. It has been reported that the loss of muscle mass associated with sarcopenia not only entails a decrease in muscle mass but also changes in muscle architecture. Knowledge on changes in muscle architecture is essential since it is one of the most important determinants on muscle strength and thus physical performance. The main objective of this study is to investigate changes in muscle architecture and physical performance during acute hospitalisation and after discharge in older adults and subsequently the effectiveness of resistance training of the lower limb during acute hospitalisation. If successful, our study could have a great impact on the individual, as well as societal level, due to a better understanding of the factors related to sarcopenia and the prevention of functional decline as a result of hospitalisation.

Interventions

OTHERResistance training

Moderate resistance training by a innovative training robot 2 times a day during hospitalisation

Sponsors

University of Copenhagen
CollaboratorOTHER
Nottingham University Hospitals NHS Trust
CollaboratorOTHER
Odense University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* ≥65 years of age * Able to ambulate before hospitalization (with/without assistance) * Able to communicate with the research team * Expected length of stay ≥2 days * Residing on Funen

Exclusion criteria

* Able to ambulate without assistance during current hospitalization * Known severe dementia * Positive Confusion and Assessment Method score * Patients who have received less than 3 resistance training sessions at discharge * Terminal illness * Recent major surgery or lower extremity bone fracture in the last 3 months * Conditions contradicting use of ROBERT(unstable vertebral-, pelvic, or lower extremity fractures * high intracranial pressure * pressure ulcers or risk of developing pressure ulcers due to fragile skin * patients with medical instability) * Metastases at femur hip * Deemed not suitable for resistance training sessions with the robot by the healthcare professional.

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline B-mode ultrasonographyBaseline (day of hospitalisation) to day of discharge from hospital (an average of a week).Muscle architecture of the m Vastus Lateralis assessed with B-mode ultrasonography.
Change from baseline 4 meter Gait Speed TestBaseline (Day of hospitalisation) to day of discharge from hospital (an average of a week).Physical performance evaluated by the 4m Gait Speed test

Secondary

MeasureTime frameDescription
Change from baseline BioimpedanceBaseline (day of hospitalisation) to day of discharge from hospital (an average of a week)Muscle quantity (kg) on wholebody level evaluated by Bioimpedance
Length of hospital stayBaseline (day of hospitalisation) to day of discharge from hospital (an average of a week)Number of days hospitalised
Change from baseline 30s Chair Stand testBaseline (day of hospitalisation) to day of discharge from hospital (an average of a week)Maximal muscle strength of the lower extremities evaluated by the 30s Chair Stand Test or the m30s Chair Stand Test (Modified).
Unplanned hospitalisationDay of discharge from hospital to 3-months follow-upPatients will be followed through a review of medical records for any unplanned Adminstrative registers will be used to assess any unplanned hospitalisation during the period of inclusion.
Individual level of physiotherapyBaseline (day of hospitalisation) to 3-months follow-upAdminstrative registers and municipalities health records will be used to assess the individual level of physiotherapy (minutes of consultation) in the period of inclusion.
MortalityBaseline (day of hospitalization) to 3-months follow-upAdministrative registers will be used to assess mortality
Change from baseline Barthel-Index 100 (Shahs version)Baseline (day of hospitalisation) to day of discharge from hospital (an average of a week)Functional level evaluated by The Barthel-Index 100 (Shahs version)

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 26, 2026